newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

  • Relmada Therapeutics, Inc. will hold one-on-one meetings with senior management at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA.
  • The conference is scheduled to take place from September 8 to 10, 2026.
  • Interested parties must contact their Wells Fargo representative to arrange a meeting.
  • Relmada is a clinical-stage biotechnology company focused on oncology & central nervous system disorders.
  • Lead candidates NDV-01 & sepranolone are advancing through clinical development.